Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues.
Ontology highlight
ABSTRACT: Cisplatin is a major cancer chemotherapeutic drug. It kills cancer cells by damaging their DNA, mainly in the form of Pt-d(GpG) diadducts. However, it also has serious side effects, including nephrotoxicity and hepatotoxicity that limit its usefulness. Chronotherapy is taking circadian time into account during therapy to improve the therapeutic index, by improving efficacy and/or limiting toxicity. To this end, we tested the impact of clock time on excision repair of cisplatin-induced DNA damage at single-nucleotide resolution across the genome in mouse kidney and liver. We found that genome repair is controlled by two circadian programs. Repair of the transcribed strand (TS) of active, circadian-controlled genes is dictated by each gene's phase of transcription, which falls across the cir
SUBMITTER: Yang Y
PROVIDER: S-EPMC6003508 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
ACCESS DATA